1. Home
  2. CE vs AMRX Comparison

CE vs AMRX Comparison

Compare CE & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celanese Corporation

CE

Celanese Corporation

SELL

Current Price

$48.70

Market Cap

5.5B

Sector

Industrials

ML Signal

SELL

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

SELL

Current Price

$21.14

Market Cap

6.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CE
AMRX
Founded
1918
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.4B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
CE
AMRX
Price
$48.70
$21.14
Analyst Decision
Buy
Strong Buy
Analyst Count
18
7
Target Price
★ $63.39
$24.29
AVG Volume (30 Days)
1.4M
★ 3.4M
Earning Date
11-02-2026
11-03-2026
Dividend Yield
★ 0.25%
N/A
EPS Growth
23.62
★ 157.89
EPS
★ 2.21
0.29
Revenue
★ $9,544,000,000.00
N/A
Revenue This Year
$4.47
$6.38
Revenue Next Year
N/A
$9.21
P/E Ratio
★ $22.16
$73.21
Revenue Growth
N/A
★ N/A
52 Week Low
$35.39
$11.45
52 Week High
$70.70
$22.07

Technical Indicators

Market Signals
Indicator
CE
AMRX
Relative Strength Index (RSI) 49.61 53.52
Support Level $43.28 $18.90
Resistance Level $49.63 $21.21
Average True Range (ATR) 2.19 0.85
MACD -0.06 -0.00
Stochastic Oscillator 33.90 61.96

Price Performance

Historical Comparison
CE
AMRX

About CE Celanese Corporation

Celanese is a global specialty chemicals manufacturer. It operates in two segments: acetyl chain, and engineered materials. Acetyl chain profitability is exposed to commodity-linked raw materials and product pricing spreads. Engineered materials converts basic chemicals into higher-margin specialty polymers and compounds engineered for specific customer applications in automotive, medical, electronics, and industrial end markets.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: